-
1
-
-
0030757461
-
Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
-
Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-107.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1075-1107
-
-
Black, R.J.1
Bray, F.2
Ferlay, J.3
Parkin, D.M.4
-
2
-
-
0026782113
-
Colon cancer overview
-
Greenwald P. Colon cancer overview. Cancer 1992; 70: 1206-15.
-
(1992)
Cancer
, vol.70
, pp. 1206-1215
-
-
Greenwald, P.1
-
3
-
-
0032414932
-
Survival of colorectal cancer patients in Europe during the period 1978-1989
-
Gatta G, Faivre J, Capocaccia R, Ponz de Leon M, the EUROCARE Working Group. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998; 34: 2176-83.
-
(1998)
Eur J Cancer
, vol.34
, pp. 2176-2183
-
-
Gatta, G.1
Faivre, J.2
Capocaccia, R.3
Ponz De Leon, M.4
-
4
-
-
0020358908
-
Role of collagenases in tumor cell invasion, tissue degradation, and cancer
-
Liotta LA, Thorgeirsson UP, Garbisa S. Role of collagenases in tumor cell invasion, tissue degradation, and cancer. Cancer Metastasis Rev 1982; 1: 277-97.
-
(1982)
Cancer Metastasis Rev
, vol.1
, pp. 277-297
-
-
Liotta, L.A.1
Thorgeirsson, U.P.2
Garbisa, S.3
-
5
-
-
0027535914
-
Biology and biochemistry of proteinases in tumor invasion
-
Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-95.
-
(1993)
Physiol Rev
, vol.73
, pp. 161-195
-
-
Mignatti, P.1
Rifkin, D.B.2
-
6
-
-
0021780949
-
Plasminogen activators, tissue degradation and cancer
-
Danö K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985; 44: 139-266.
-
(1985)
Adv Cancer Res
, vol.44
, pp. 139-266
-
-
Danö, K.1
Andreasen, P.A.2
Grondahl-Hansen, J.3
Kristensen, P.4
Nielsen, L.S.5
Skriver, L.6
-
7
-
-
0025055183
-
Plasminogen activator inhibitors: Hormonally regulated serpins
-
Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990; 68: 1-19.
-
(1990)
Mol Cell Endocrinol
, vol.68
, pp. 1-19
-
-
Andreasen, P.A.1
Georg, B.2
Lund, L.R.3
Riccio, A.4
Stacey, S.N.5
-
8
-
-
0025983254
-
Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis
-
Sier CFM, Verspaget HW, Griffioen G, et al. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis. Gastroenterology 1991; 101: 1522-8.
-
(1991)
Gastroenterology
, vol.101
, pp. 1522-1528
-
-
Sier, C.F.M.1
Verspaget, H.W.2
Griffioen, G.3
-
9
-
-
0025844891
-
Plasminogen activator inhibitor in human carcinoma tissues
-
Tanaka N, Fukao H, Ueshima S, Okada K, Yasutomi M, Matsuo O. Plasminogen activator inhibitor in human carcinoma tissues. Int J Cancer 1991; 48: 481-4.
-
(1991)
Int J Cancer
, vol.48
, pp. 481-484
-
-
Tanaka, N.1
Fukao, H.2
Ueshima, S.3
Okada, K.4
Yasutomi, M.5
Matsuo, O.6
-
10
-
-
0026655384
-
Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues
-
Nakamura M, Konno H, Tanaka T, et al. Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thromb Res 1992; 65: 709-19.
-
(1992)
Thromb Res
, vol.65
, pp. 709-719
-
-
Nakamura, M.1
Konno, H.2
Tanaka, T.3
-
11
-
-
0028363578
-
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression
-
De Vries TJ, Quax PHA, Denijn M, et al. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 1994; 144: 70-81.
-
(1994)
Am J Pathol
, vol.144
, pp. 70-81
-
-
De Vries, T.J.1
Quax, P.H.A.2
Denijn, M.3
-
12
-
-
0025127815
-
Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
-
Jänicke F, Schmitt M, Hafter R, et al. Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 1990; 4: 69-78.
-
(1990)
Fibrinolysis
, vol.4
, pp. 69-78
-
-
Jänicke, F.1
Schmitt, M.2
Hafter, R.3
-
13
-
-
0026440080
-
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
-
Foekens JA, Schmitt M, van Putten WLJ, et al. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 1992; 52: 6101-5.
-
(1992)
Cancer Res
, vol.52
, pp. 6101-6105
-
-
Foekens, J.A.1
Schmitt, M.2
Van Putten, W.L.J.3
-
14
-
-
0026739437
-
Urokinase plasminogen activator, a strong and independent prognostic marker in breast cancer
-
Duffy MJ, Reilly D, Nolan N, O'Higgins N, Fennelly JJ, Andreasen P. Urokinase plasminogen activator, a strong and independent prognostic marker in breast cancer. Fibrinolysis 1992; 6: 55-7.
-
(1992)
Fibrinolysis
, vol.6
, pp. 55-57
-
-
Duffy, M.J.1
Reilly, D.2
Nolan, N.3
O'Higgins, N.4
Fennelly, J.J.5
Andreasen, P.6
-
15
-
-
0027223048
-
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
-
Gröndahl-Hansen J, Christensen IJ, Rosenquist C, et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993; 53: 2513-21.
-
(1993)
Cancer Res
, vol.53
, pp. 2513-2521
-
-
Gröndahl-Hansen, J.1
Christensen, I.J.2
Rosenquist, C.3
-
16
-
-
0032953135
-
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with type-1 inhibitor (PAI-1) in breast cancer
-
De Witte JH, Sweep CGJ, Klijn JGM, et al. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with type-1 inhibitor (PAI-1) in breast cancer. Br J Cancer 1999; 80: 286-94.
-
(1999)
Br J Cancer
, vol.80
, pp. 286-294
-
-
De Witte, J.H.1
Sweep, C.G.J.2
Klijn, J.G.M.3
-
17
-
-
0033109360
-
Cathepsin D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: An immunohistochemical study of prognostic value and relations to tenascin-C and other factors
-
Jahkola T, Toivonen T, von Smitten K, et al. Cathepsin D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors. Br J Cancer 1999; 80: 167-74.
-
(1999)
Br J Cancer
, vol.80
, pp. 167-174
-
-
Jahkola, T.1
Toivonen, T.2
Von Smitten, K.3
-
18
-
-
0028070859
-
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
-
Pedersen H, Brunner N, Francis D, et al. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 1994; 54: 4671-5.
-
(1994)
Cancer Res
, vol.54
, pp. 4671-4675
-
-
Pedersen, H.1
Brunner, N.2
Francis, D.3
-
19
-
-
0028321634
-
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
-
Nekarda H, Schmitt M, Ulm K, et al. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 1994; 54: 2900-7.
-
(1994)
Cancer Res
, vol.54
, pp. 2900-2907
-
-
Nekarda, H.1
Schmitt, M.2
Ulm, K.3
-
20
-
-
0026603255
-
The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer
-
Hasui Y, Marutsuka K, Suzumiya J, Kitada S, Osada Y, Sumiyoshi A. The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer. Int J Cancer 1992; 50: 871-3.
-
(1992)
Int J Cancer
, vol.50
, pp. 871-873
-
-
Hasui, Y.1
Marutsuka, K.2
Suzumiya, J.3
Kitada, S.4
Osada, Y.5
Sumiyoshi, A.6
-
21
-
-
0022473105
-
Tissue-type plasminogen activator in breast cancer: Relationship with estradiol and progesterone receptors
-
Duffy MJ, O'Grady P, Simon J, Rose M, Lijnen HR. Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors. J Natl Cancer Inst 1986; 77: 621-3.
-
(1986)
J Natl Cancer Inst
, vol.77
, pp. 621-623
-
-
Duffy, M.J.1
O'Grady, P.2
Simon, J.3
Rose, M.4
Lijnen, H.R.5
-
22
-
-
0025995880
-
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer
-
Jänicke F, Schmitt M, Graeff H. Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer. Semin Thromb Hemost 1991; 17: 303-12.
-
(1991)
Semin Thromb Hemost
, vol.17
, pp. 303-312
-
-
Jänicke, F.1
Schmitt, M.2
Graeff, H.3
-
23
-
-
0023244770
-
Plasminogen activators and tumor development in the human colon: Activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas
-
De Bruin PAF, Griffioen G, Verspaget HW, Verheijen JH, Lamers CBHW. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas. Cancer Res 1987; 46: 4654-7.
-
(1987)
Cancer Res
, vol.46
, pp. 4654-4657
-
-
De Bruin, P.A.F.1
Griffioen, G.2
Verspaget, H.W.3
Verheijen, J.H.4
Lamers, C.B.H.W.5
-
24
-
-
0029086080
-
Prognostic value of plasminogen activators and their inhibitors in colorectal cancer
-
Verspaget HW, Sier CFM, Ganesh S, Griffioen G, Lamers CBHW. Prognostic value of plasminogen activators and their inhibitors in colorectal cancer. Eur J Cancer 1995; 31A: 1105-9.
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 1105-1109
-
-
Verspaget, H.W.1
Sier, C.F.M.2
Ganesh, S.3
Griffioen, G.4
Lamers, C.B.H.W.5
-
25
-
-
0027935805
-
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
-
Ganesh S, Sier CFM, Griffioen G, et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 1994; 54: 4065-75.
-
(1994)
Cancer Res
, vol.54
, pp. 4065-4075
-
-
Ganesh, S.1
Sier, C.F.M.2
Griffioen, G.3
-
26
-
-
0027968819
-
Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer
-
Mulcahy HE, Duffy MJ, Gibbons D, et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 1994; 344: 583-4.
-
(1994)
Lancet
, vol.344
, pp. 583-584
-
-
Mulcahy, H.E.1
Duffy, M.J.2
Gibbons, D.3
-
27
-
-
8244225180
-
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
-
Ganesh S, Sier CFM, Heerding MM, et al. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. Br J Cancer 1997; 75: 1793-801.
-
(1997)
Br J Cancer
, vol.75
, pp. 1793-1801
-
-
Ganesh, S.1
Sier, C.F.M.2
Heerding, M.M.3
-
28
-
-
0001554828
-
The classification of cancer of the rectum
-
Dukes CE. The classification of cancer of the rectum. J Path Pract 1932; 35: 323-32.
-
(1932)
J Path Pract
, vol.35
, pp. 323-332
-
-
Dukes, C.E.1
-
29
-
-
0001646225
-
The grading of carcinoma
-
Broders AC. The grading of carcinoma. Minn Med 1925; 8: 726.
-
(1925)
Minn Med
, vol.8
, pp. 726
-
-
Broders, A.C.1
-
32
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding
-
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
34
-
-
0025968060
-
Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse
-
Ossowski L, Russo-Payne H, Wilson EL. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res 1991; 51: 274-81.
-
(1991)
Cancer Res
, vol.51
, pp. 274-281
-
-
Ossowski, L.1
Russo-Payne, H.2
Wilson, E.L.3
-
35
-
-
0027283371
-
Prevention of metastasis by inhibition of the urokinase receptor
-
Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci 1994 USA; 90: 5021-5.
-
Proc Natl Acad Sci 1994 USA
, vol.90
, pp. 5021-5025
-
-
Crowley, C.W.1
Cohen, R.L.2
Lucas, B.K.3
Liu, G.4
Shuman, M.A.5
Levinson, A.D.6
|